Literature DB >> 16153378

[Quality of life of patients treated with oral anticoagulants].

M Yanes Baonza, A Cabrera Majada, J M Ferrer García-Borrás, R Sánchez González.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16153378      PMCID： PMC8207888          DOI： 10.1157/13078601

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  5 in total

1.  The effect of self-monitoring the INR on quality of anticoagulation and quality of life.

Authors:  W Kulinna; D Ney; T Wenzel; D L Heene; J Harenberg
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

2.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

Authors:  M E Cromheecke; M Levi; L P Colly; B J de Mol; M H Prins; B A Hutten; R Mak; K C Keyzers; H R Büller
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

3.  [Cross-cultural adaptation of a questionnaire for measuring the quality of life of patients taking oral anticoagulants].

Authors:  R Sánchez González; M Yanes Baonza; A Cabrera Majada; J M Ferrer García-Borrás; R Alvarez Nido; E Barrera Linares
Journal:  Aten Primaria       Date:  2004-10-31       Impact factor: 1.137

4.  Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.

Authors:  S Jo-Anne Wilson; Philip S Wells; Michael J Kovacs; Geoffrey M Lewis; Janet Martin; Erica Burton; David R Anderson
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

5.  A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

Authors:  P T Sawicki
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272
  5 in total
  1 in total

1.  Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance.

Authors:  Emilio Márquez-Contreras; Nieves Martell-Claros; Vicente Gil-Guillén; Mariano De la Figuera-Von Wichmann; Eugenio Sánchez-López; Ines Gil-Gil; Sara Márquez-Rivero
Journal:  Qual Life Res       Date:  2017-01-06       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.